Wenn Kommunikation zur Hürde wird: Unterstützungssysteme für pflegende An- und Zugehörige im Fokus

Communication difficulties are among the most burdensome situations in dementia. As conversations become more difficult and mutual understanding declines, those affected often experience increased frustration and social isolation. But it's not just those with the illness who suffer: a current review highlights that communication barriers are a cause of stress and burnout for caregivers. Support...

Kommunikation als Schlüssel: Wege zur personalisierten Demenzpflege

In modern dementia care, personalized care is a crucial factor for quality of life. This brings one question to the forefront: How can healthcare professionals recognize and meet the individual needs of those affected as verbal communication becomes more difficult? A current systematic review from London provides answers to this. The research team analyzed 33 studies…

Diagnose, Prognose, Prävention: Wie Gedächtnisambulanzen mit Patienten kommunizieren

The medical care of people with Alzheimer's dementia (AD) is undergoing a fundamental paradigm shift. As deposits in the brain associated with the development of the disease can be detected decades before the first symptoms, early stages of the disease and personalized medicine are increasingly coming into focus. This change presents professionals, particularly in...

Wie sollte eine Demenz-Diagnose kommuniziert werden?

The communication of a dementia diagnosis or mild cognitive impairment (MCI) is a significant moment that fundamentally changes the lives of those affected and their families and loved ones. To provide professionals with evidence-based strategies for this sensitive task, a research team from the University of Pennsylvania has conducted 23 studies on the topic…

digiDEM Bayern-Statement zu Lecanemab

The decision by the Joint Federal Committee (G-BA) of February 19, 2026, to classify the additional benefit of Lecanemab as ‚not proven‘ confirms the skepticism of the digiDEM project management regarding the clinical relevance of this therapy. While the only study available so far on Lecanemab shows a statistically significant difference between the drug and a placebo at the end of the study...

The Live-In Model: Opportunities and Challenges in Dementia Care

Live-in caregivers who reside in the homes of individuals with dementia for a limited period can provide significant relief for family members and informal caregivers. These „live-in helpers,“ often referred to as „24-hour caregivers,“ typically do not have formal nursing training and are primarily intended to provide support with household tasks and daily care. Often the case...